ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Anthony Sanneh as Chief Executive Officer, Chief Financial Officer and Secretary

Effective as of May 15, 2022 (as originally reported on Form 8-K filed on April 21, 2022), Anthony Sanneh resigned as Chief Executive Officer, Chief Financial Officer and Secretary of the Company. Mr. Sanneh's resignation was not due to any disagreement with the Company on any matter relating to its operations, policies or practices.

Appointment of Thomas Spruce as Chief Executive Officer, Chief Financial Officer and Secretary

On May 18, 2022, Thomas Spruce was appointed as the Company's Chief Executive Officer, Chief Financial Officer and Secretary, in addition to his existing offices as the President, Chief Operating Officer and sole Director of the Company, effective immediately.





Biography of Thomas Spruce

Thomas Spruce, age 66, is the Company's President, Chief Operating Officer and sole Director. Mr. Spruce has decades of experience in large corporations, small companies, and start-ups in a variety of sales management, operations management, business development, and consulting roles with product and service businesses. From 2008 to the present, Mr. Spruce has served as the President and CEO of His Speed, Inc., a company that specializes in business management, development, and consulting. Prior to 2008, Mr. Spruce served in management positions at the Principle Pharmacy Group, MediqPRN/Hill-Rom and Owen Healthcare/Cardinal Health, where he managed sales, operations management, business transition, integrated sales, and enterprise account management. Mr. Spruce has a Bachelor of Sciences in Pharmacy from the University of Arkansas, is a licensed pharmacist, is a Board Member at The Victory Way, has served as Board Chairman of the Dean's Advisory Council- Western University School of Pharmacy and was a Fellow at the American College of Healthcare Executives.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS





Exhibits

Certain exhibits listed below are incorporated by reference as so marked with the date and filing with which such exhibits were filed with the Securities and Exchange Commission).





17.1*     Correspondence from Anthony Sanneh (originally filed as an exhibit to
        the Company' Current Report on Form 8-K dated April 21, 2022)
101     Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in
        Inline XBRL (Inline eXtensible Business Reporting Language).
104     Cover Page Interactive Data File (embedded within the Inline XBRL document
        and included in Exhibit 101).




  2

© Edgar Online, source Glimpses